Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)

Conditions

• Chemotherapy-induced Nausea and Vomiting

Interventions

• DRUG: NEPA (300mg netupitant/0.5mg palonosetron)
• DRUG: Granisetron, 2 mg (oral) or 1 mg (IV) OR Palonosetron, 0.5 mg (oral), 0.25mg (IV) OR Ondansetron, 16 mg (oral) or 8 mg (IV) OR Dolasetron 100 mg (oral) OR Tropisetron 5 mg (oral or IV)
• DRUG: Dexamethasone, 8 mg (oral) or equivalent IV dose

Sponsor

Helsinn Healthcare SA